In vitro and in vivo evaluation of levofloxacin sustained-release capsules

Drug Development and Industrial Pharmacy

Volumn 37, Issue 1, 2011, Pages 33-40

  Yin, Li Fang ^a   Huang, Shi Jing ^a   Jiang, Shu Guang ^a   Zhao, Chun Jie ^a   Pei, Zhi Qiang ^a   Zhang, Qiang ^b  

^a CHINA PHARMACEUTICAL UNIVERSITY   (China)

^b PEKING UNIVERSITY HEALTH SCIENCE CENTER   (China)

Author keywords

Bioavailability; Fluidized bed; Levofloxacin; Pellets; Sustained release

Indexed keywords

ETHYL CELLULOSE; GELATIN; LEVOFLOXACIN;

ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DOG; DRUG BIOAVAILABILITY; DRUG PELLET; DRUG SCREENING; DRUG SOLUTION; FLUIDIZED BED; MALE; NONHUMAN; PATIENT COMPLIANCE; SINGLE DRUG DOSE; STATISTICAL ANALYSIS; SUSTAINED RELEASE PREPARATION;

ANIMALS; BIOLOGICAL AVAILABILITY; CAPSULES; CELLULOSE; CHEMISTRY, PHARMACEUTICAL; DELAYED-ACTION PREPARATIONS; DOGS; DRUG ADMINISTRATION SCHEDULE; DRUG IMPLANTS; EXCIPIENTS; MALE; OFLOXACIN; SOLUBILITY; TECHNOLOGY, PHARMACEUTICAL;

EID: 78649987480     PISSN: 03639045     EISSN: 15205762     Source Type: Journal    
DOI: 10.3109/03639045.2010.489562     Document Type: Article

References (29)

1. Isaac GS. (1994). Multiparticulate oral drug delivery. New York: Marcel Dekker.
2. Kim M, Kim J, You Y, Park H, Lee S, Park J, et al. (2007). Development and optimization of a novel oral controlled delivery system for tamsulosin hydrochloride using response surface methodology. Int J Pharm, 341:97-104.
3. Muschert S, Siepmann F, Leclercq B, Carlin B, Siepmann J. (2009). Prediction of drug release from ethylcellulose coated pellets. J Control Release, 135:71-9.
4. Timmermans J, Amighi K, Puigdevall J, Baltes E, Moes AJ. (1998). Peroral sustained-release film-coated pellets as a means to overcome physicochemical and biological drug-related problems. II. Bioavailability and tolerance assessment in dogs. Drug Dev Ind Pharm, 24:517-25.
5. Tomer G, Podczeck F, Newton JM. (2002). The influence of model drugs on the preparation of pellets by extrusion/ spheronization: II spheronization parameters. Int J Pharm, 231:107-19.
6. Hemati M, Cherif R, Saleh K, Pont V. (2003). Fluidized bed coating and granulation: Influence of process-related variables and physicochemical properties on the growth kinetics. Powder Technol, 130:18-34.
7. Cui Y, Zhang Y, Tang X. (2008). In vitro and in vivo evaluation of ofloxacin sustained-release pellets. Int J Pharm, 156:175-80.
8. Hu L, Liu Y, Tang X, Zhang Q. (2006). Preparation and in vitro/in vivo evaluation of sustained-release metformin hydrochloride pellets. Eur J Pharm Biopharm, 64:185-92.
9. Tang X, Tian X, Ci L. (2004). Preparation and evaluation of pH-dependent gradient-release pellets for TCM. Drug Dev Ind Pharm, 30:1079-87.
10. Ho H, Chen C, Sheu M. (2000). Influence of pluronic F-68 on dissolution and bioavailability characteristics of multiple-layer pellets of nifedipine for controlled release delivery. J Control Release, 68:433-40.
11. Davis R, Bryson HM. (1994). Levofloxacin: A review of its antibacterial activity, pharmacokinetics and therapeutic efficacy. Drugs, 47:677-700.
12. Langtry HD, Lamb HM. (1999). Levofloxacin: Its use in infections of the respiratory tract, skin, soft tissues and urinary tract. Drugs, 56:487-515.
13. Noviello S, Ianniello F, Leone S, Esposito S. (2002). Comparative in vitro bacteriostatic and bactericidal activity of levofloxacin and ciprofloxacin against urinary tract pathogens determined by MIC, MBC, Time-Kill curves and bactericidal index analysis. Infez Med, 10:100-6.
14. Fatemeh S, James L, Ali R. (2003). The influence of drug type on the release profiles from Surelease-coated pellets. Int J Pharm, 254:123-35.
15. Sadeghi F, Ford JL, Rubinstein MH, Rajabi-Siahboomi AR. (2000). Comparative study of drug release from pellets coated with HPMC or Surelease. Drug Dev Ind Pharm, 26:651-60.
16. Sadeghi F, Ford JL, Rubinstein MH, Rajabi-Siahboomi AR. (2001). Study of drug release from pellets coated with surelease containing hydroxypropylmethylcellulose. Drug Dev Ind Pharm, 27:419-30.
17. Sousa JJ, Sousa A, Moura MJ, Podczeck F, Newton JM. (2002). The influence of core materials and film coating on the drug release from coated pellets. Int J Pharm, 233:111-22.
18. Thoma K, Ziegler I. (1998). The pH-independent release of fenoldopam from pellets with insoluble film coats. Eur J Pharm Biopharm, 46:105-13.
19. Goole J, Amighi K, Vanderbist F. (2008). Evaluation and floating enhancement of levodopa sustained release floating minitablets coated with insoluble acrylic polymer. Drug Dev Ind Pharm, 34:827-33.
20. Huang HF, Lu Y, He HB, Tang X. (2008). Preparation and bioavailability of sustained-release doxofylline pellets in beagle dogs. Drug Dev Ind Pharm, 34:676-82.
21. Kramar A, Turk S, Vrecer F. (2003). Statistical optimization of diclofenac sustained-release pellets coated with polymethacrylic films. Int J Pharm, 256:43-52.
22. Tian L, Zhang Y, Tang X. (2008). Sustained-release pellets prepared by combination of wax matrices and double-layer coatings for extremely water-soluble drugs. Drug Dev Ind Pharm, 34:569-76.
23. Zhang X, Tang X, Yang R. (2009). Development of a tamsulosin hydrochloride controlled-release capsule consisting of two different coated pellets. Drug Dev Ind Pharm, 35:26-33.
24. Umprayn K, Chitropas P, Amarekajorn S. (1999). Development of terbutaline sulfate sustained-release coated pellets. Drug Dev Ind Pharm, 25:477-91.
25. Xie H, Gan Y, Ma S, Gan L, Chen Q. (2008). Optimization and evaluation of time-dependent tablets comprising an immediate and sustained release profile using artificial neural network. Drug Dev Ind Pharm, 34:363-72.
26. Ouyang D, Nie S, Li W, Guo H, Liu H, Pan W. (2005). In vitro and in vivo evaluation of two extended release preparations of combination metformin and glipizide. Drug Dev Ind Pharm, 31:677-85.
27. Yang M, Cui F, You B, Yang M, Tao A, Cun D, et al. (2005). In vivo evaluation of two novel controlled-release nitrendipine formulations. Drug Dev Ind Pharm, 31:589-95.
28. Amighi K, Timmermans J, Puigdevall J, Baltes E, Moes AJ. (1998). Peroral sustained-release film-coated pellets as a means to overcome physicochemical and biological drug-related problems. I. In vitro development and evaluation. Drug Dev Ind Pharm, 24:509-15.
29. Royce A, Li S, Weaver M, Shah U. (2004). In vivo and in vitro evaluation of three controlled release principles of 6-N-cyclohexyl- 2'-O-methyladenosine. J Control Release, 97:79-90.